Bard vs Covidien hernia mesh lawsuit is a question thousands of patients face right now. Both manufacturers sold surgical mesh that allegedly caused serious complications. However, these are two separate legal actions with different courts, timelines, and settlement status. Understanding the Bard vs Covidien hernia mesh lawsuit distinction matters because it determines where you file, what you may recover, and how long the process takes.
If you had hernia repair surgery and experienced complications, this guide explains which case applies to you. We strongly recommend consulting a licensed mass tort attorney before taking any legal action.
What Is the Bard Hernia Mesh Lawsuit?
C.R. Bard manufactured several popular hernia mesh products. These include the Composix Kugel, Ventralex ST, PerFix Plug, and 3DMax lines. Bard was acquired by Becton, Dickinson and Company (BD) in 2017. Plaintiffs allege the polypropylene mesh degrades inside the body over time. This degradation reportedly causes chronic inflammation, mesh migration, and organ adhesion. The FDA issued Class I recalls for the Composix Kugel patch starting in 2005. Those recalls cited a memory recoil ring that could break and perforate the bowel.
The Bard hernia mesh lawsuit is consolidated in multidistrict litigation as MDL 2846. It sits in the U.S. District Court for the Southern District of Ohio. Judge Edmund A. Sargus Jr. oversees approximately 23,700 pending cases as of May 2026. In October 2024, BD agreed to a global settlement covering roughly 38,000 to 40,000 claims. The total settlement value is estimated to exceed one billion dollars.
Settlement payments use a points-based system tied to injury severity. Disbursements began in 2025 and continue through 2026. An Intensive Settlement Process is scheduled to launch in January 2027. On the other hand, plaintiffs who filed after the initial window may still pursue claims through the ongoing MDL process. Average individual payouts reportedly range from $60,000 to $100,000. Severe cases involving bowel resection or permanent disability may exceed $200,000.
What Is the Covidien Hernia Mesh Lawsuit?
Covidien manufactured the Parietex and Symbotex mesh product lines. Medtronic acquired Covidien in January 2015. Unlike Bard mesh, the Covidien Parietex mesh uses a polyester base with an absorbable collagen film coating. Plaintiffs allege this collagen coating degrades too quickly after implantation. When the coating fails, raw mesh is exposed to bowel and internal organs. This allegedly causes adhesions, fistulas, and the need for complex revision surgery.
The Covidien hernia mesh lawsuit is consolidated as MDL 3029. It is located in the U.S. District Court for the District of Massachusetts. Judge Patti B. Saris oversees approximately 2,350 pending cases. In contrast to Bard, no global settlement has been reached with Covidien or Medtronic. The first bellwether trial was originally set for February 2026. However, the judge canceled that date and rescheduled it for July 13, 2026. A second bellwether trial is expected to follow.
The FDA has issued several recalls for Covidien mesh products. In October 2018, over 7,300 units of Parietex Composite Parastomal Mesh were recalled. Additional recalls followed in 2021 and 2023. The Bard vs Covidien hernia mesh lawsuit difference here is significant. Covidien cases focus on coating chemistry defects. Bard cases focus on polypropylene material degradation. Both involve mass tort claims, but they proceed through entirely separate legal tracks.
Bard vs Covidien Hernia Mesh Lawsuit — Key Differences
| Factor | Bard (BD) | Covidien (Medtronic) |
|---|---|---|
| MDL Number | MDL 2846 | MDL 3029 |
| Federal Court | Southern District of Ohio | District of Massachusetts |
| Pending Cases (2026) | ~23,700 | ~2,350 |
| Settlement Status | Global settlement processing ($1B+) | No settlement — bellwether trial July 2026 |
| Key Mesh Defect Alleged | Polypropylene degradation and shrinkage | Collagen coating failure on polyester mesh |
| Major Products | Composix Kugel, Ventralex, PerFix, 3DMax | Parietex Composite, Symbotex, ProGrip |
| Estimated Individual Payout | $60,000 — $100,000 average; severe cases $200,000+ | Unknown — pending bellwether outcomes |
| Case Trajectory | Wind-down and payment phase | Active pre-trial litigation |
The most important distinction in the Bard vs Covidien hernia mesh lawsuit comparison is timing. Bard cases have a defined settlement framework. Claimants accepted into the global settlement are receiving payments now. Similarly, both cases involve alleged design defects that caused revision surgeries. However, Covidien claimants face a longer timeline. The July 2026 bellwether trial will likely shape any future settlement discussions. No payout structure exists yet for Covidien claims.
Another critical difference involves case volume. The Bard MDL dwarfs the Covidien docket by roughly ten to one. While this means Bard cases resolved faster through a global deal, some attorneys believe Covidien claimants hold stronger individual leverage. A smaller docket and no global settlement may result in higher per-case value. The Bard vs Covidien hernia mesh lawsuit outcome for each plaintiff depends heavily on which product was implanted.
Eligibility for the Bard vs Covidien Hernia Mesh Lawsuit
General eligibility requirements are similar for both the Bard and Covidien lawsuits. You typically must have received a hernia mesh implant and suffered a qualifying complication. Common qualifying injuries include mesh migration, bowel obstruction, chronic pain, infection, adhesion, fistula, or hernia recurrence. You generally need to have undergone revision surgery or have a surgeon’s recommendation for one. Medical records documenting mesh-related injury are essential. Learn more about how to qualify for a mass tort.
Statute of limitations rules vary by state. Most states allow two to three years from the date of discovery. The discovery rule means the clock starts when you knew or should have known your injury was mesh-related. This is important because many complications appear years after surgery. Even if your implant was placed a decade ago, you may still qualify if symptoms developed recently. You can check your basic eligibility using the eligibility quiz tool.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
For Bard cases specifically, new claims can still be filed in MDL 2846. However, participation in the global settlement depends on meeting the settlement administrator’s criteria. For Covidien cases, the litigation remains open and actively accepting new plaintiffs. Understanding which manufacturer made your mesh is the critical first step in the Bard vs Covidien hernia mesh lawsuit process. Your surgical records should identify the specific product implanted.
Which One Applies to Your Situation
The Bard vs Covidien hernia mesh lawsuit that applies to you depends entirely on which mesh was implanted. If your surgeon used a Bard product like the Ventralex, PerFix, 3DMax, or Composix Kugel, your case falls under MDL 2846. You may qualify for the existing global settlement. If your surgeon used a Covidien product like Parietex, Symbotex, or ProGrip, your case falls under MDL 3029. You would be joining active litigation with a bellwether trial approaching.
If you experienced complications and are unsure which mesh brand was used, request your operative report. Your hospital or surgeon’s office is required to provide this record. The report will identify the device manufacturer, product name, and lot number. This information is essential for any Bard vs Covidien hernia mesh lawsuit filing. An experienced mass tort lawyer can also help you obtain and interpret these records.
Both paths offer potential recovery for serious injuries. The Bard path currently provides more certainty because settlement terms already exist. The Covidien path carries more uncertainty but potentially higher individual value. Neither path guarantees a specific outcome. Your attorney can evaluate the strength of your claim based on your medical history, the product involved, and your state’s legal requirements. You can also explore other active MDL cases and comparison guides on our site to better understand how mass torts differ from class actions.
Frequently Asked Questions
Can I file a lawsuit against both Bard and Covidien?
Typically, no. Your claim targets the specific manufacturer of the mesh implanted in your body. In the Bard vs Covidien hernia mesh lawsuit landscape, each case is product-specific. Your surgical records will identify which company made your device. If you had multiple hernia repairs with different brands, you could potentially file separate claims. Consult an attorney to review your specific medical history.
Is it too late to file a hernia mesh lawsuit in 2026?
Not necessarily. New Bard claims are still being filed in MDL 2846. Covidien MDL 3029 remains in active litigation and accepts new cases. The Bard vs Covidien hernia mesh lawsuit timeline depends on your state’s statute of limitations. Many states apply the discovery rule. This means your filing deadline runs from when you learned your complications were mesh-related. However, delays can weaken your case. Filing sooner is always better.
How long does it take to receive a hernia mesh settlement payment?
For Bard cases in the global settlement, disbursements began in 2025. Processing continues through 2026 and beyond. Administrative review of individual claims takes time. Some Bard claimants may not receive payment until late 2026 or 2027. For Covidien cases, no settlement framework exists yet. The Bard vs Covidien hernia mesh lawsuit timeline for Covidien claimants depends on bellwether trial outcomes starting July 2026. Resolution could take significantly longer.
Check If You May Qualify
Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.
Official Sources & Resources
For verified mass tort and MDL information:
- JPML: jpml.uscourts.gov — official MDL statistics and transfer orders
- DOJ: justice.gov — settlement announcements and press releases
- FDA: fda.gov — drug recalls, warning letters, and safety alerts
- CDC: cdc.gov — health condition data and exposure guidelines
- EPA: epa.gov — environmental contamination data
- Cornell LII: law.cornell.edu — plain-English legal definitions
Content last reviewed May 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.
Related Guides
- All Active MDL Cases
- More in This Category
- Tort Reform by State — 50-State Comparison
- All 50 State Tort Reform Guides
- Mass Tort Explainers
- Demographic Guides
- Mass Tort Tips
- Georgia Tort Reform Guide
- Florida Tort Reform Guide
- Ohio Tort Reform Guide
You May Also Like
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.